Related references
Note: Only part of the references are listed.Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer
Tao Zhang et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Reframing recalcitrance for small-cell lung cancer
F. H. Blackhall
ANNALS OF ONCOLOGY (2021)
Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy
Weixiang Qi et al.
CANCER BIOMARKERS (2021)
Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy
Lingling Li et al.
FRONTIERS IN ONCOLOGY (2021)
Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients
Xiangjuan Ma et al.
THORACIC CANCER (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
Tumor-infiltrating lymphocytes in the immunotherapy era
Sterre T. Paijens et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer
Kei Sonehara et al.
THORACIC CANCER (2020)
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types
Tom van den Ende et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer
Dickran Kazandjian et al.
JAMA ONCOLOGY (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita et al.
JAMA ONCOLOGY (2018)
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Corinne Faivre-Finn et al.
LANCET ONCOLOGY (2017)
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysisaEuro
D. De Ruysscher et al.
ANNALS OF ONCOLOGY (2016)
Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis
Xiuxiu Zhang et al.
CANCER BIOMARKERS (2016)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Cigarette Smoking and Variations in Systemic Immune and Inflammation Markers
Meredith S. Shiels et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression
Beatrice Philip et al.
CARCINOGENESIS (2013)
Targeting lactate metabolism for cancer therapeutics
Joanne R. Doherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
The Warburg effect and mitochondrial stability in cancer cells
Vladimir Gogvadze et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Influence of sex on toxicity and treatment outcome in small-cell lung cancer
S Singh et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
DB Fried et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)